Related Experiment Video
Updated: Aug 10, 2026

05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Adiponectin gene haplotype is associated with preeclampsia
Tanja Saarela1, Mikko Hiltunen, Seppo Helisalmi
1Department of Obstetrics and Gynaecology, University of Kuopio, Kuopio, Finland.
Genetic Testing
|March 21, 2006
Summary
Genetic variations in the adiponectin gene may influence preeclampsia risk. Specific adiponectin gene polymorphisms showed a weak but significant association with preeclampsia susceptibility in Finnish women.
Area of Science:
- Genetics
- Obstetrics
- Molecular Biology
Background:
- Preeclampsia is a serious pregnancy complication.
- Adiponectin, an adipokine, plays a role in metabolic and vascular functions.
- The genetic contribution to preeclampsia susceptibility is not fully understood.
Purpose of the Study:
- To investigate the association between adiponectin gene polymorphisms and preeclampsia risk.
- To determine if specific single nucleotide polymorphisms (SNPs) in the adiponectin gene are linked to preeclampsia in Finnish women.
Main Methods:
- Genotyping of 133 preeclamptic women and 245 controls for two adiponectin gene SNPs (rs2244673/SNP45 and rs1799858/SNP276).
- Chi-squared analysis to compare genotype and allele frequencies between groups.
- Haplotype analysis using the expectation-maximization (EM) algorithm to estimate haplotype frequencies.
Main Results:
- The TT genotype at SNP276 was associated with protection against preeclampsia (OR 0.27, p=0.012).
- Significant differences in genotype (p=0.035) and allele (p=0.043) frequencies for SNP276 were observed between preeclamptic and control groups.
- Adiponectin gene haplotype analysis revealed significant overrepresentation of pooled G haplotypes versus TT haplotype in the preeclampsia group (p=0.042 +/- 0.005).
- No significant differences were found for SNP45 genotype or allele distributions.
Conclusions:
- Adiponectin gene polymorphisms exhibit a weak, statistically significant haplotype association with preeclampsia susceptibility in Finnish women.
- The findings suggest a potential role for adiponectin gene variants in the pathogenesis of preeclampsia.
Related Concept Videos
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...